【4694】ビー・エム・エル
臨床検査。
類似企業:
【業界1位】
H.U.グループホールディングス
【業界1位】
H.U.グループホールディングス
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
---|---|---|---|---|---|---|---|---|---|---|
2025.03 | 2025/02/07 | Q3予 | 140,000 | → | 9,200 | → | 9,700 | → | 6,100 | → |
2025.03 | 2024/11/08 | Q2予 | 140,000 | → | 9,200 | → | 9,700 | ↑ | 6,100 | → |
2025.03 | 2024/08/09 | Q1予 | 140,000 | → | 9,200 | → | 9,200 | → | 6,100 | → |
2025.03 | 2024/05/10 | 当初予 | 140,000 | - | 9,200 | - | 9,200 | - | 6,100 | - |
2024.03 | 2024/05/10 | 実 | 137,964 | ↑ | 9,167 | ↑ | 9,605 | ↑ | 6,034 | ↑ |
2024.03 | 2024/02/09 | Q3予 | 135,000 | → | 8,500 | ↓ | 9,000 | ↓ | 5,500 | ↓ |
2024.03 | 2023/11/10 | Q2予 | 135,000 | → | 11,500 | → | 11,800 | ↑ | 7,600 | → |
2024.03 | 2023/08/10 | Q1予 | 135,000 | → | 11,500 | → | 11,500 | → | 7,600 | → |
2024.03 | 2023/05/12 | 当初予 | 135,000 | - | 11,500 | - | 11,500 | - | 7,600 | - |
2023.03 | 2023/05/12 | 実 | 159,462 | ↑ | 23,936 | ↑ | 24,182 | ↑ | 15,578 | ↑ |
2023.03 | 2023/04/24 | 修正予 | 159,000 | ↑ | 23,500 | ↑ | 24,000 | ↑ | 15,000 | ↑ |
2023.03 | 2023/02/10 | Q3予 | 154,000 | → | 22,000 | → | 22,500 | → | 14,500 | → |
2023.03 | 2022/11/11 | Q2予 | 154,000 | ↑ | 22,000 | ↑ | 22,500 | ↑ | 14,500 | ↑ |
2023.03 | 2022/08/10 | Q1予 | 146,000 | → | 16,500 | → | 16,500 | → | 11,000 | → |
2023.03 | 2022/05/13 | 当初予 | 146,000 | - | 16,500 | - | 16,500 | - | 11,000 | - |
2022.03 | 2022/05/13 | 実 | 186,067 | ↑ | 48,889 | ↑ | 51,077 | ↑ | 33,741 | ↑ |
2022.03 | 2022/04/25 | 修正予 | 186,000 | ↑ | 48,800 | ↑ | 51,000 | ↑ | 33,700 | ↑ |
2022.03 | 2022/02/09 | Q3予 | 177,000 | ↑ | 42,500 | ↑ | 44,000 | ↑ | 28,000 | ↑ |
2022.03 | 2021/11/11 | Q2予 | 154,000 | → | 32,000 | → | 33,100 | ↑ | 20,900 | → |
2022.03 | 2021/08/11 | Q1予 | 154,000 | ↑ | 32,000 | ↑ | 32,000 | ↑ | 20,900 | ↑ |
2022.03 | 2021/05/13 | 当初予 | 142,300 | - | 19,200 | - | 19,200 | - | 12,700 | - |
2021.03 | 2021/05/13 | 実 | 138,571 | ↑ | 19,936 | ↑ | 20,803 | ↑ | 13,711 | ↑ |
2021.03 | 2021/04/26 | 修正予 | 138,500 | ↑ | 19,800 | ↑ | 20,700 | ↑ | 13,500 | ↑ |
2021.03 | 2021/02/10 | Q3予 | 133,500 | ↑ | 17,000 | ↑ | 17,500 | ↑ | 10,500 | ↑ |
2021.03 | 2020/11/10 | Q2予 | 121,000 | ↑ | 10,000 | ↑ | 11,000 | ↑ | 7,000 | ↑ |
2021.03 | 2020/08/11 | 当初予 | 117,450 | - | 7,350 | - | 7,350 | - | 4,850 | - |
2020.03 | 2020/05/13 | 実 | 120,732 | ↑ | 9,763 | ↑ | 10,211 | ↑ | 6,375 | ↑ |
2020.03 | 2020/05/08 | 修正予 | 120,700 | ↑ | 9,700 | ↓ | 10,200 | ↓ | 6,300 | ↓ |
2020.03 | 2020/02/07 | Q3予 | 120,100 | → | 10,600 | → | 11,100 | → | 6,800 | → |
2020.03 | 2019/11/08 | Q2予 | 120,100 | → | 10,600 | → | 11,100 | ↑ | 6,800 | → |
2020.03 | 2019/08/09 | Q1予 | 120,100 | → | 10,600 | → | 10,600 | → | 6,800 | → |
2020.03 | 2019/05/10 | 当初予 | 120,100 | - | 10,600 | - | 10,600 | - | 6,800 | - |
2019.03 | 2019/05/10 | 実 | 117,129 | ↑ | 10,450 | ↑ | 10,880 | ↑ | 6,646 | ↑ |
2019.03 | 2019/02/08 | Q3予 | 115,100 | → | 9,550 | → | 10,050 | → | 6,130 | → |
2019.03 | 2018/11/09 | Q2予 | 115,100 | → | 9,550 | → | 10,050 | ↑ | 6,130 | → |
2019.03 | 2018/08/09 | Q1予 | 115,100 | → | 9,550 | - | 9,550 | ↓ | 6,130 | → |
2019.03 | 2018/05/11 | 当初予 | 115,100 | - | - | - | 10,050 | - | 6,130 | - |
2018.03 | 2018/05/11 | 実 | - | - | - | - | - | - | - | - |
2018.03 | 2018/02/09 | Q3予 | 114,000 | → | 9,400 | → | 9,750 | → | 5,960 | → |
2018.03 | 2017/11/08 | Q2予 | 114,000 | → | 9,400 | → | 9,750 | → | 5,960 | → |
2018.03 | 2017/08/09 | Q1予 | 114,000 | → | 9,400 | → | 9,750 | → | 5,960 | → |
2018.03 | 2017/05/10 | 当初予 | 114,000 | - | 9,400 | - | 9,750 | - | 5,960 | - |
2017.03 | 2017/05/10 | 実 | 111,243 | ↓ | 9,329 | ↓ | 9,711 | ↓ | 5,948 | ↓ |
2017.03 | 2017/02/10 | Q3予 | 111,500 | → | 9,480 | → | 9,890 | → | 6,110 | → |
2017.03 | 2016/11/08 | Q2予 | 111,500 | ↑ | 9,480 | ↑ | 9,890 | ↑ | 6,110 | ↑ |
2017.03 | 2016/05/10 | 当初予 | 110,500 | - | 8,700 | - | 9,200 | - | 5,500 | - |
2016.03 | 2016/05/10 | 実 | 109,024 | ↑ | 8,429 | ↑ | 8,830 | ↑ | 5,424 | ↑ |
2016.03 | 2016/04/25 | 修正予 | 109,000 | ↑ | 8,400 | ↑ | 8,800 | ↑ | 5,400 | ↑ |
2016.03 | 2016/02/08 | 修正予 | 108,000 | ↑ | 7,700 | ↑ | 8,100 | ↑ | 4,800 | ↑ |
2016.03 | 2015/11/10 | Q2予 | 106,500 | → | 7,100 | → | 7,550 | → | 4,300 | → |
2016.03 | 2015/08/12 | Q1予 | 106,500 | → | 7,100 | - | 7,550 | → | 4,300 | → |
2016.03 | 2015/05/11 | 当初予 | 106,500 | - | - | - | 7,550 | - | 4,300 | - |
2015.03 | 2015/05/11 | 実 | - | - | - | - | - | - | - | - |
2015.03 | 2015/02/09 | Q3予 | 104,350 | → | 6,650 | → | 7,050 | → | 3,810 | → |
2015.03 | 2014/11/11 | Q2予 | 104,350 | → | - | - | 7,050 | → | 3,810 | → |
2015.03 | 2014/08/14 | Q1予 | 104,350 | ↑ | 6,650 | ↓ | 7,050 | ↓ | 3,810 | ↓ |
2015.03 | 2014/05/12 | 当初予 | 101,000 | - | 8,200 | - | 8,500 | - | 4,900 | - |
2014.03 | 2014/05/12 | 実 | 99,047 | - | 8,188 | - | 8,582 | - | 4,990 | - |